Identification and characteristics of patients with axial psoriatic arthritis: clinical, phenotypic, and imaging associations (2025)
https://pubmed.ncbi.nlm.nih.gov/40059325/

Development and implementation of the international AIDA network spondylarthritis registry (2025)
https://pubmed.ncbi.nlm.nih.gov/40027889/

Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry (2025)
https://pubmed.ncbi.nlm.nih.gov/39893938/

The Spondyloarthritides: From Scientific and Therapeutic Immobility to the Forefront of Rheumatology Research (2024)
https://pubmed.ncbi.nlm.nih.gov/39974591/

Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry (2024)
https://pubmed.ncbi.nlm.nih.gov/38759119/

Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic Arthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/38282940/

Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study (2023)
https://pubmed.ncbi.nlm.nih.gov/37610650/

Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review (2023)
https://pubmed.ncbi.nlm.nih.gov/37150489/